Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00521742
Recruitment Status : Completed
First Posted : August 28, 2007
Last Update Posted : February 28, 2012
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):